Paradigm Biocapital Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Paradigm Biocapital Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-251,777	Closed	-$23.4M	–	31
2021 Q4	$23.4M	Buy	+251,777	New	+$16.6M	6.68%	5

Paradigm Biocapital Advisors's ARNA Position: Q1 2022 in Review

Paradigm Biocapital Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 251,777 shares — an estimated $23.4M sold.

Paradigm Biocapital Advisors first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $23.4M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Paradigm Biocapital Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Paradigm Biocapital Advisors sold 251,777 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $23.4M.
Paradigm Biocapital Advisors first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Paradigm Biocapital Advisors's Arena Pharmaceuticals Inc position peaked at $23.4M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Paradigm Biocapital Advisors's 13F filing for Q1 2022, filed 16 May 2022.